Development and validation of a preoperative nomogram for predicting postoperative high drainage output after robot-assisted Roux-en-Y hepaticojejunostomy for children with choledochal cysts: based on cyst diameter, age, and other indicators Authors: Jing Zhang, Tao You, Xinke Qin, Chong Liang, Zhenchuang Zhu, Xin Liu, Siqi Ji, Xiaoqiong He, Xufei Duan, Xueqiang Yan Published: 2026 ABSTRACT AbstractBackgroundRobot-assisted Roux-en-Y hepaticojejunostomy (RYHJ) is the standard treatment for choledochal cysts (CDC). Routine abdominal drainage is typically placed, but no reliable preoperative tool exists to identify patients at risk of high drainage output (≥ 2 mL·kg⁻1·d⁻1), limiting early drain removal or selective omission under close monitoring. This study aimed to develop and validate an intuitive preoperative nomogram using readily available clinical indicators (e.g., cyst diameter, age) to predict high-drainage risk after robot-assisted RYHJ and support individualized drainage management.MethodsThis single-center retrospective cohort study enrolled 129 children with CDC who underwent da Vinci robot-assisted RYHJ. Based on weight-adjusted daily drain output, patients were divided into low-drainage (< 2 mL·kg⁻1·d⁻1, n = 30) and high-drainage (≥ 2 mL·kg⁻1·d⁻1, n = 99) groups. Potential predictors were identified via univariate and multivariate logistic regression and incorporated into a nomogram. Model performance was assessed using the area under the receiver operating characteristic curve (AUC) and calibration plots.ResultsMultivariate analysis identified younger age as an independent predictor of high drainage output (OR = 0.983, 95% CI: 0.972–0.994), and larger cyst diameter as a potential predictor showing a trend toward association (OR = 1.321, 95% CI: 0.979–1.783). The final nomogram, incorporating cyst diameter, age, body mass index (BMI), hemoglobin (HGB), and globulin (GLB), showed good discrimination (AUC = 0.753) and calibration. The optimal risk threshold was 79.88%, yielding a specificity of 75.9%, and, using an optimal threshold, identifies low-risk patients suitable for early drain removal protocols to guide individualized drainage management.ConclusionWe have developed and validated a nomogram model based on "cyst diameter + age" (supplemented by BMI, HGB, and GLB) that enables noninvasive, precise assessment of high-drainage risk following robot-assisted RYHJ. Notably, the model identifies a low-risk subset—older children with smaller cysts—for whom early drain removal (e.g., within 24–48 h) is safe, and in whom selective drain omission could be prospectively evaluated under rigorous monitoring. This risk-stratified approach has the potential to reduce drain-related complications and optimize ERAS pathways following robot-assisted RYHJ. As this is an internal validation only, external validation in independent cohorts is warranted before clinical implementation.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12893-026-03912-1.Keywords: Choledochal cyst (CDC), Robot-assisted Roux-en-Y hepaticojejunostomy (RYHJ), Nomogram, High drainage output, Enhanced recovery after surgery (ERAS), Pediatric surgery Introduction Choledochal cyst (CDC), a common congenital biliary malformation in children, requires excision combined with Roux-en-Y hepaticojejunostomy (RYHJ) to prevent severe complications [1, 2]. Traditionally, abdominal drainage has been routinely placed to monitor postoperative complications such as bleeding or anastomotic leakage. However, advancements in surgical techniques, particularly the precision offered by robot-assisted platforms, has significantly decreased the incidence of major anastomotic complications [3, 8]. This improved safety profile, coupled with the availability of alternative monitoring methods (e.g., serial laboratory tests and point-of-care ultrasound (POCUS) [9, 12]), challenges the necessity of routine drainage for all patients. Consequently, the focus of drain management is shifting from passive monitoring to an active management of drainage volume and quantitative decision-making, with the ultimate goal of safely removing the drain early, or even attempting "drainage-free" management in carefully selected low-risk patients. Multiple previous studies have provided strong evidence that cyst diameter is a clinically relevant predictor of postoperative outcomes in children with choledochal cysts. A recent multicenter study by Ding et al. included cyst diameter as a candidate predictor for postoperative bile leakage after choledochal cyst excision [13]. Zhou et al. identified cyst diameter > 5 cm as a significant risk factor for conversion from laparoscopy to open surgery in children with extrahepatic choledochal cysts, noting that large cysts often cause severe inflammation and increased intraoperative bleeding [14]. Based on this existing evidence, we first tested cyst diameter as a standalone predictor in our cohort (Step 1, AUC = 0.633), not as a claim of statistical significance from our own data alone, but as a hypothesis‑driven starting point grounded in established clinical observations. Currently, there is lacking a reliable tool to preoperatively distinguish whether the postoperative abdominal drainage output is high or low. This study aims to develop and validate a nomogram based on easily accessible preoperative variables (cyst diameter and age) to predict the risk of high postoperative drainage (≥ 2 mL·kg⁻1·d⁻1). This model provides an evidence-based foundation for individualized drainage strategies, paving the way for exploring "drain-free" protocols within enhanced recovery after surgery (ERAS) programs. Methods Children with CDC This single-centre, retrospective cohort study consecutively enrolled 129 children with CDC who underwent Da Vinci robot-assisted RYHJ at the Department of Hepatobiliary Surgery, Wuhan Children's Hospital (Tongji Medical College, Huazhong University of Science and Technology), between October 2020 and September 2024. The following clinical data were collected for the children with CDC: sex, age, cyst diameter (measured by preoperative MRI/CT), body mass index (BMI), and preoperative laboratory indices, including liver function (total bilirubin [TBil], alanine aminotransferase [ALT], aspartate aminotransferase [AST], albumin [ALB], and globulin [GLB], complete blood count: haemoglobin [HGB]), and inflammatory markers (C-reactive protein [CRP]); amylase (serum amylase [AMY-S] and urine amylase [AMY-U]); and postoperative daily abdominal drain output (mL). No imputation was performed for missing data; patients with significant missing data were excluded (see Exclusion Criteria). Clinical trial number Not applicable. Inclusion criteria CDC: Children aged 0–18 years with a clinically and radiologically confirmed diagnosis of CDC who underwent robot-assisted RYHJ, had complete preoperative imaging data (ultrasound, CT, or MRI) for accurate cyst diameter measurement, documented postoperative daily drain output volume (mL), and complete medical records without significant missing data. Exclusion criteria Complex congenital malformations, prior abdominal surgery (re-operative), critical missing data, or guardian refusal for participation/medical record use. Grouping of low- and high-drainage groups Based on the principles of ERAS, previous studies have suggested that abdominal drain removal may be considered in pediatric patients with CDC after robot-assisted RYHJ when the daily drainage output is < 2 mL·kg⁻1·d⁻1 [15]. In this study, we recorded daily drain output from postoperative day 1 (POD 1) until the day of drain removal. Each morning at 8:00 AM, the total drain output (mL) over the preceding 24 h was measured by the nursing staff and then divided by the patient’s body weight (kg) to obtain the weight‑adjusted daily output (mL·kg⁻1·d⁻1). The same time interval was used for all patients.Patients were classified into two groups based on whether any day during the drainage period reached or exceeded the threshold: Low‑drainage group: weight‑adjusted daily output < 2 mL·kg⁻1·d⁻1 on every day of drainage. Low‑drainage group: weight‑adjusted daily output < 2 mL·kg⁻1·d⁻1 on every day of drainage. High‑drainage group: weight‑adjusted daily output ≥ 2 mL·kg⁻1·d⁻1 on at least one day of drainage. High‑drainage group: weight‑adjusted daily output ≥ 2 mL·kg⁻1·d⁻1 on at least one day of drainage. The average daily output over the drainage period was not used for group assignment, because the clinical concern is whether high output ever occurs, not the mean value. The screening process and grouping of the children with CDC are shown in Fig. 1. Patient stratification and clinical correlation. This flowchart outlines the categorization of patients into groups according to their postoperative drainage output, and demonstrates the comparative analysis of demographic and clinical features after robot-assisted RYHJ for children with CDC Observation indicators and definitions The primary outcome measure was the daily postoperative abdominal drain output (mL), which was normalized to body weight (mL·kg⁻1·d⁻1). Core predictor variables were preoperative cyst diameter (cm) and age of the children with CDC. Additional variables analyzed included sex, BMI, and preoperative laboratory indices (TBil, ALT, AST, GLB, HGB, etc.). Statistical analysis All statistical analyses were performed using IBM SPSS Statistics 27.0 (IBM Corp., Armonk, NY, USA) and R software (version 4.1.0). A two-tailed *p*-value < 0.05 was considered statistically significant. Univariate and multivariate analysis Continuous variables were compared using the independent samples *t*-test or Mann–Whitney U test, as appropriate based on data distribution. Categorical variables were compared using the chi-square (χ2) test or Fisher's exact test. Variables with a *p*-value < 0.05 in univariate analysis, along with clinically relevant variables (cyst diameter), were entered into a multivariate binary logistic regression model to identify independent risk factors for postoperative high-drainage volume. This hypothesis-driven sequential adjustment approach was used for prediction model development, not p-value-based selection. To further assess the relationship between cyst diameter and postoperative high drainage volume, we constructed a series of multivariate logistic regression models with sequential adjustment for potential confounders. Model 1 was adjusted for age; Model 2 was adjusted for age, GLB, and HGB; Model 3 was further adjusted for BMI. Nomogram development and validation Based on the independent risk factors identified in the multivariate analysis, we developed a preoperative nomogram to predict the risk of postoperative high-drainage volume. This was constructed using the rms package in R software. The model's discriminative ability was assessed by calculating the concordance index (C-index), which is equivalent to the area under the receiver operating characteristic curve (AUC). Due to the single‑center retrospective design, external validation was not performed. Instead, we performed internal validation using bootstrap resampling (1000 repetitions) to obtain bias‑corrected estimates of model performance. The cohort was also randomly split into training (70%) and internal validation (30%) sets to assess discrimination and calibration. Therefore, the term "validation" throughout this manuscript refers exclusively to internal validation. Determination of the optimal risk threshold The model generates a risk probability (from 0 to 100%) for each patient. To determine the optimal cut-off value for classifying patients into high- and low-drainage groups, we performed ROC curve analysis. Youden's J index (J = Sensitivity + Specificity—1) was calculated for all possible probability thresholds. The threshold that maximized Youden index was selected as the optimal cut-off, as it represents the best statistical trade-off between sensitivity and specificity. Results Comparison of intraoperative and postoperative outcomes between the two groups All children with CDC (low-drainage group, n = 30; high-drainage group, n = 99) successfully underwent da Vinci robot-assisted RYHJ without conversion to open surgery or perioperative deaths. According to the Todani classification, 112 children were Type I (86.8%) and 17 were Type IV (13.2%), with no significant difference in distribution between the two groups (*p* > 0.05) (see Table 2 for details). Table 2The differences between the two subtypes were assessed using univariate analysisAll (N = 129)Low Drainage (n = 30)High Drainage (n = 99)ZP valueAge [M (Q1, Q3), Months]38.6 (21, 72.5)68.8 (35.75, 102)36 (17.5, 60.8)−3.4850.0005Weight [M (Q1, Q3), Kg]10 (14, 19.5)20.25 (13.5. 30.375)13.5 (10, 17)−3.735 < 0.001Sex (male/female)24/1052/2822/77−1.9110.056CDC Todani classification (I/IV)107/2226/481/18−0.6160.538BMI15.54 (14.75, 16.64)15.86 (14.62, 18.445)15.43 (14.81, 16.54)−1.3580.175Cyst diameter [M (Q1, Q3), cm]2.7 (1.8, 4.0)2 (1.33, 3)3 (1.9, 4)−2.2650.024Direct bilirubin [M (Q1, Q3), µmol/L]3.4 (2.4, 8.8)3 (2.25, 4.8)3.9 (2.5, 10.7)−1.2740.203Total bilirubin [M (Q1, Q3), µmol/L]8.7 (5.6, 19.05)8.1 (4.475, 11)9.5 (5.9, 21.7)−1.9570.050ALP [M (Q1, Q3), U/L]254 (210, 349)242 (202.25, 328.25)260 (210, 351)−0.7280.467ALT [M (Q1, Q3), U/L]44 (18, 125)44 (10.75, 119.25)44 (20, 133)−0.7220.47AST [M (Q1, Q3), U/L]45 (29, 90.5)37 (21.5, 74.5)46 (31.25, 93.25)−1.8020.072R-glutamyltranspeptidase [M (Q1, Q3), U/L]107 (32.5, 347.5)83.5 (16, 248.25)116 (34, 383)−1.1510.25Total bile acids [M (Q1, Q3), μmol/L]5.35 (2.8, 11.725)5.5 (2.2, 11.8)5.2 (2.85, 12.8)−0.0730.942ALB albumin [M (Q1, Q3), g/L]45.4 (43.7, 47.3)45.5 (43.575, 47.35)45.3 (43.7, 47.3)−0.3010.763GLB globulin [M (Q1, Q3), g/L]21 (18.3, 23.7)21.75 (19.9, 26.15)20.9 (17.6, 23.2)−2.0240.043CRP [M (Q1, Q3), mg/L]3.22 (1.87, 7.55)3.19 (1.64, 10.18)3.22 (1.97, 7.26)−0.0280.977WBC [M (Q1, Q3), 10^9/L]8.02 (6.2, 10.33)7.57 (5.7725, 10.68)8.06 (6.445, 10.06)−0.1360.892HGB hemoglobin [M (Q1, Q3), g/L]118 (110, 127)123 (115.5, 129.25)118 (109, 125)−2.1440.032PLT platelet count [M (Q1, Q3), 10^9/L]365 (275, 429)318.5 (266.75, 424.75)367 (280.5, 429.5)−0.7920.428Serum amylase [M (Q1, Q3), U/L]78.5 (52.25, 208.25)82 (48, 194)76 (53, 216)−0.0510.959Urinary amylase [M (Q1, Q3), U/L]281 (130, 691.5)245 (110, 539.5)298.5 (144, 830)−0.8540.393 The differences between the two subtypes were assessed using univariate analysis No statistically significant differences were observed between the two groups regarding intraoperative blood loss, operative time, postoperative hospital stay, or total hospitalization costs (all *p* > 0.05; Table 1). Table 1Comparison of intraoperative and postoperative outcomes between two groups of pediatric patientsAll (N = 129)Low Drainage (n = 30)High Drainage (n = 99)ZpIntraoperative blood loss [M (Q1, Q3), mL]10 [5,10]10 [5,20]10 [5,10]−0.4960.620Operative duration [M (Q1, Q3), min]270 [230, 305]284 [220, 305]265 [230, 310]−0.0780.938Postoperative hospital stay [M (Q1, Q3), d]10 [9, 12.5]9 [8,12]10 [9,13]−0.9840.325Total expense [M (Q1, Q3), yuan]66,176.38 [59862.84, 73,084.02]66,297.46 [57478.73, 70,923.99]66,047.03 [60072.54, 74,223.81]−0.8530.394Rate of conversion of laparotomy0%0%0% Comparison of intraoperative and postoperative outcomes between two groups of pediatric patients Baseline characteristics comparison between the two groups Comparisons between the two groups (refer to Table 2) revealed significant differences (*p* < 0.05) in cyst diameter (high-drainage: 3.0 cm [2.4, 4.0] vs. low-drainage: 2.0 cm [1.5, 2.7]), weight (high-drainage: 13.5 kg [10.0, 17.0] vs. low-drainage: 20.25 kg [13.50, 30.375]), age (high-drainage: 35 months [17.0, 60.0] vs. low-drainage: 68.5 months [35.75, 102]), preoperative GLB (high-drainage 23.1 g/L [19.9, 26.3] vs. low-drainage 26.0 g/L [24.0, 28.0]), and preoperative HGB (high-drainage 112.0 g/L [104.0, 120.0] vs. low-drainage 121.0 g/L [112.0, 129.0]) (Table 2). No statistically significant differences were observed in other variables, including BMI, TBil, AST, ALT, ALB, CRP, AMY-S, AMY-U (all *p* > 0.05). Impact of cyst diameter on postoperative abdominal drainage volume To assess the independent predictive efficacy of cyst diameter for postoperative high drainage volume, we conducted a ROC curve analysis in a univariate context. Cyst diameter produced an AUC of 0.633 (95% CI: 0.512–0.754) for predicting high drainage volume (see the blue curve in Fig. 2). According to Swets' diagnostic accuracy classification (AUC = 0.5–0.7: low accuracy; 0.7–0.9: moderate accuracy), this parameter exhibited limited discriminative ability as a standalone predictor (AUC < 0.7). ROC curves comparing the performance of different predictive models for postoperative drainage tube insertion. The models incrementally incorporate the following preoperative variables: cyst diameter; cyst diameter & age; cyst diameter, Age, Hemoglobin (HGB) & Globulin (GLB); and Cyst Diameter, Age, HGB, GLB & Body Mass Index (BMI) Multivariate logistic regression analysis Variables that were statistically significant (*p* < 0.05) in the univariate analysis (Table 2) were included in the multivariate logistic regression model (Table 3). The analysis revealed that cyst diameter was a potential predictor showing a trend toward association with high drainage volume postoperatively. Cyst diameter showed a non‑significant trend toward association (adjusted OR = 1.321, 95% CI: 0.979–1.783; *p* = 0.068). Table 3Regression analysis resultsSignificance LevelExponential of B (Exp(B))95% Confidence Interval for Exp(B)lower boundupper boundCyst diameter0.0681.3210.9791.783Age [Months]0.0020.9830.9720.994Preoperative GLB0.1740.9440.8691.026Preoperative HGB0.7630.9970.9791.015 Regression analysis results In contrast, age emerged as an independent protective factor. For each additional month of age, the risk decreased by 1.6% (adjusted OR = 0.983, 95% CI: 0.972–0.994; *p* = 0.002). Interestingly, preoperative GLB (adjusted OR = 0.944, 95% CI: 0.869–1.026; *p* = 0.174) and HGB (adjusted OR = 0.997, 95% CI: 0.979–1.015; *p* = 0.763) exhibited inter-group differences in the univariate analysis but lost statistical significance in the multivariate model. The predictive model incorporating cyst diameters and age demonstrated significantly better discriminative performance for postoperative high drainage volume (AUC = 0.741, 95% CI: 0.641–0.842, green curve in Fig. 2) than the model that only considered cyst diameter. Construction and optimization of the nomogram model Based on the study hypothesis and the results of multivariate analysis (age as an independent predictor, cyst diameter showing a trend, *p* = 0.068), we constructed an initial model including both variables. We then sequentially added GLB, HGB, and BMI to improve calibration, not solely based on statistical significance. This sequential adjustment was hypothesis-driven, grounded in biological plausibility and clinical face validity, rather than a p-value-based forward selection. Specifically, the initial nomogram (including only cyst diameter and age) showed poor calibration (Fig. 3a). Subsequently, we incorporated preoperative serum GLB and HGB—both showing significant intergroup differences in univariate analysis—as covariates, yielding an extended model. This model showed improved goodness-of-fit and calibration compared to the initial model (Fig. 3b), and the AUC value increased to 0.746 (95% CI: 0.649–0.843; pink curve in Fig. 2). . (a) Initial nomogram including cyst diameter and age. (b) Extended nomogram incorporating preoperative serum GLB and HGB. (c) Final model further including BMI. To further optimize the model, we evaluated the contribution of other variables to the calibration performance (data not shown). Notably, although there was no difference in BMI between groups in the univariate analysis (*p* > 0.05), including BMI significantly improved calibration performance (Fig. 3c vs. b) and marginally increased the AUC to 0.753 (95% CI: 0.653–0.853; purple curve, Fig. 2). Model calibration assessment Model calibration was evaluated using the Hosmer–Lemeshow goodness-of-fit test. Participants were divided into ten equal-sized groups based on their predicted probabilities, and observed event rates were compared to predicted probabilities across deciles. A non-significant result (*p* > 0.05) indicates adequate model calibration. The results showed that the model was well calibrated (Fig. 4c, χ2 = 10.33, *p* = 0.243). A preoperative nomogram for predicting the probability of high postoperative drainage output after robot-assisted RYHJ for children with CDC. To use the nomogram, locate the patient’s value for each variable (cyst diameter, age, BMI, HGB, and GLB) on the corresponding axis, draw a vertical line upward to the ‘Points’ axis to obtain the individual score, sum all five scores, and then locate this total on the ‘Total Points’ axis. Draw a vertical line downward to the ‘Predicted Value’ axis to read the estimated probability of belonging to the high-drainage group (≥ 2 mL·kg⁻1·d⁻1). The dashed line at a probability of 79.88% indicates the optimal risk threshold determined by ROC analysis and Youden's index maximization; probabilities ≥ 79.88% support classification into the high-drainage group and recommendation for drain retention until output falls below 2 mL·kg⁻1·d⁻1. This nomogram is intended for risk stratification to guide early removal or selective omission under monitoring, not as a standalone rule for drain-free management Therefore, the final model integrates five variables: age, cyst diameter, BMI, HGB, and GLB, generating a nomogram with enhanced predictive efficacy (Fig. 4c). Risk threshold and application of the nomogram Based on ROC curve analysis and the maximization of Youden’s index, the optimal risk probability threshold for identifying the high-drainage group was determined to be 79.88%. At this threshold, the model demonstrated the following classification performance: sensitivity of 70.1% (95% CI: 60.5%–78.5%), specificity of 75.9% (95% CI: 66.2%–84.0%), positive predictive value of 81.4%, and negative predictive value of 63.2% (see Supplement Table 1 for details). The high specificity ensures that low-risk patients are unlikely to be misclassified, thereby supporting selective clinical management. The nomogram in Fig. 4 provides a practical tool for implementing this threshold in clinical practice. To estimate a patient’s probability of belonging to the high-drainage group, perform the following steps: For each predictor (cyst diameter, age, BMI, HGB, and GLB), locate the corresponding value on its respective axis and draw a vertical line to the “Points” axis to obtain the individual score (e.g., 3 cm cyst diameter ≈ 33 points; 36 months of age ≈ 80 points; BMI 16 kg/m2 ≈ 54 points; HGB 110 g/L ≈ 24 points; GLB 20 g/L ≈ 50 points). Sum all five scores to obtain a total point value (e.g., 33 + 80 + 54 + 24 + 50 = 241 points). On the “Total Points” axis, locate the total score and draw a vertical line downward to the “Predicted Value” axis to read the estimated probability (e.g., 241 points corresponds to ≈85%). Since the estimated probability (≈85%) meets the predefined high-risk threshold, the patient is classified into the high-drainage group. Accordingly, postoperative retention of the intraperitoneal drain is recommended until the output decreases below 2 mL·kg⁻1·d⁻1. Discussion This study successfully developed and validated a preoperative nomogram that accurately predicts the risk of high postoperative drainage output following robot-assisted RYHJ in children with CDC. Our model identified younger age as a key independent risk factor and showed a trend for larger cyst diameter as a potential predictor of high postoperative drainage. Physiologically, younger children, particularly infants, have a higher extracellular fluid-to-body weight ratio and a more reactive peritoneum, which may contribute to increased postoperative exudation. Although the statistical significance of cyst diameter was not reached (i.e., it was non‑significant by conventional thresholds), we retained it for three primary reasons. First, the rationale is grounded in a clear pathophysiological mechanism: a larger cyst diameter necessitates a wider surgical dissection and creates a larger anastomotic area, which directly contributes to increasing lymphatic disruption and inflammatory exudation [16]. Second, its inclusion meaningfully improves the model performance, with the AUC significantly exceeding that of the age-only baseline model. Third, its prognostic value is supported by existing clinical evidence, as similar pediatric postoperative bile leakage prediction models have validated the importance of this factor [13]. Furthermore, younger age at surgery is frequently associated with earlier diagnosis—promoted by symptomatic presentation (e.g., jaundice, abdominal pain, or pancreatitis) or prenatal detection—and such cysts are often larger, with more pronounced inflammation or adhesion, potentially amplifying postoperative fluid output [14, 17, 19]. Our decision to retain this variable reflects the foundational principle of clinical prediction modeling, wherein biological plausibility and demonstrated predictive value take precedence over rigid statistical thresholds. Nonetheless, given its borderline *p*-value, the stability of cyst diameter as a potential predictor requires confirmation through future external validation studies using larger, multi-institutional cohorts. Although several factors did not meet the criteria for independent predictors or even trending associations, their notable associations in multivariate logistic regression analyses offer valuable insights for future investigation. Lower preoperative HGB and GLB levels in the high-drainage group may reflect poorer tissue oxygenation, chronic inflammation, or nutritional deficiencies—each potentially compromising healing capacity and increasing postoperative exudation [20, 23]. Similarly, the trend towards lower BMI in the high-drainage group, despite remaining within the normal range, suggests that suboptimal nutritional reserves might approach a threshold that compromises metabolic resilience under surgical stress [24, 25]. Notably, although absolute body weight differed significantly between groups (p < 0.001), we chose BMI over weight for the final nomogram. As a height-adjusted measure, BMI provides better clinical interpretability of body composition and nutritional reserves, capturing nutrition-related risk without confounding by age-related growth, thereby complementing age as the dominant predictor. While these factors were superseded by the dominant predictors of age and cyst size in our model, they may still contribute to the overall physiological background risk. This study further found no significant differences between the two groups regarding intraoperative blood loss, operation time, or Todani classification. Moreover, these variables were not included in the final multivariate model. This may suggest that, within the context of the operational precision and stability afforded by the robotic-assisted surgical platform, the direct influence of traditional surgical-related variables on postoperative drainage volume has diminished. Instead, patient-specific physiological and anatomical characteristics (such as age and cyst size) have emerged as more dominant predictors. However, it remains possible that surgical factors retain prognostic relevance in more complex cases (e.g., severe adhesions or aberrant anatomy)—a question that future multi-center studies with larger sample sizes can better address. The principal clinical value of this model lies not only in its predictive capacity but also in its potential to guide a paradigm shift in postoperative drainage management—from a routine, uniform policy toward a selective, risk-adapted strategy. The most compelling evidence supporting this shift is the excellent safety profile observed in the low-drainage group. In our cohort, none of the 30 patients in the observed low-drainage group experienced major complications (e.g., biliary leak, pancreatic leak, or intra-abdominal hemorrhage) requiring intervention. This demonstrates that low-drainage output, as predicted by our model, reliably reflects a contained, uncomplicated postoperative course. When considered alongside the already low complication rates of modern robotic surgery [3, 8], these findings provide a strong safety rationale for reevaluating the necessity of routine drain placement. Building upon this safety rationale, we propose a clear, risk-stratified clinical pathway based on our nomogram. For high-risk patients (e.g., infants with large cysts), drain placement remains mandatory and should be retained until output falls below the safe threshold of 2 mL·kg⁻1·d⁻1. Conversely, for low-risk patients (e.g., older children with small cysts), our data suggest that the conventional indication for drainage is weak. In these selected cases, we advocate actively considering strategies such as very early removal (within 24 h) or, more importantly, considering drain omission only within the context of a prospective protocol with rigorous monitoring. Avoiding drains in low-risk patients aligns perfectly with ERAS principles. This approach is expected to yield multiple benefits, including eliminating drain-related discomfort and pain, reducing the need for analgesics [26, 28], facilitating earlier mobilization, and potentially shortening hospital stays. Furthermore, it removes the risks of drain-related complications such as infection, blockage, displacement, and incision-related issues [26, 27, 29]. Our model provides the objective, data-driven tool needed to safely identify candidates for such a "drain-free" protocol—a critical missing piece in the ERAS pathway for this surgery. The optimal risk threshold of 79.88%, determined by maximizing the Youden index, demonstrated a specificity of 75.9%, minimizing misclassification of low-risk patients and thereby reducing unnecessary drain placement and associated complications. In practice, patients with a predicted probability ≥ 79.88% should routinely receive an abdominal drain retained until output is < 2 mL·kg⁻1·d⁻1, whereas those well below this threshold may be considered for early removal or a "drain-free" strategy. The developed nomogram demonstrates moderate discriminatory ability (AUC = 0.753). Although this performance is sufficient to support preliminary risk stratification, several important limitations must be acknowledged. First, due to the retrospective design, routine biochemical analysis of drain fluid (bilirubin, amylase, culture) was not performed for all patients. Consequently, we cannot definitively characterize the composition of the high output in each patient. However, clinically significant bile leak was confirmed in only 3 of 99 high‑output patients, and no patient developed pancreatic leak or intra‑abdominal abscess requiring intervention. Thus, in most cases, high output represented sterile inflammatory exudate or lymphatic fluid rather than anastomotic failure. Second, because all patients in this cohort received an abdominal drain, our model cannot directly validate a true 'drain‑free' strategy. The model's primary clinical value lies in predicting high output in drained patients, thereby supporting early removal in low‑risk patients. The safety of omitting drainage entirely in low‑risk patients identified by the nomogram requires prospective randomized evaluation. Third, this study lacks external validation. Our model was developed and internally validated using data from a single institution, which may limit its generalizability to other populations, surgical techniques, or healthcare settings. Fourth, we were unable to capture potentially important missing variables due to inconsistent documentation, including preoperative cholangitis, diameter of hepatic duct or anastomosis, operative difficulty, and severity of cyst inflammation or adhesion. These factors may influence postoperative drain output and should be incorporated in future prospective studies. Fifth, body mass index (BMI) was included solely for its contribution to model calibration, despite lacking a significant univariate group difference (*p* > 0.05). This data-driven post-hoc modification carries a potential risk of overfitting, particularly given the relatively small sample size of this single‑center cohort. Therefore, the contribution of BMI to model performance should be regarded as exploratory at this stage, and its stability and generalizability must be confirmed through external validation using larger, multi‑institutional datasets before clinical implementation. Finally, future prospective, multicenter studies with larger sample sizes and inclusion of patients undergoing different surgical modalities are warranted to externally validate our nomogram and to incorporate additional clinically relevant predictors. A prospective randomized controlled trial comparing routine drainage against a selective "drain-free" approach in low-risk patients identified by our nomogram would represent the essential next step to definitively establish the safety and superiority of this personalized management strategy. Conclusion In conclusion, we have developed and validated a robust preoperative nomogram (AUC = 0.753) that effectively stratifies the risk of high-drainage following robot-assisted RYHJ in a subset of children with CDC. By pinpointing younger age as the strongest independent predictor and larger cyst diameter as a potential predictor showing a trend toward association—supplemented by BMI (retained for calibration improvement in an exploratory manner), HGB, and GLB—this tool empowers clinicians to move beyond a one-size-fits-all protocol towards a personalized, risk-adapted drainage strategy. Using the optimal threshold of 79.88% (specificity 75.9%), the model reliably distinguishes high-risk patients, who should retain drains until output falls below 2 mL·kg⁻1·d⁻1, from a low-risk cohort. In this low-risk group, early drain removal (e.g., within 24‑48 h) is safe. Selective drain omission (i.e., no drain placed) may be considered only within future prospective protocols that include rigorous postoperative monitoring (e.g., clinical examination, point‑of‑care ultrasound, and laboratory markers). The model does not replace intraoperative or postoperative clinical judgment. Our findings provide a compelling evidence base to challenge the routine use of abdominal drains and to pioneer ERAS-aligned, minimally invasive pathways. Future prospective external validation in independent cohorts, ideally through randomized trials comparing routine versus nomogram‑guided drainage management, remains crucial before routine clinical application. Supplementary Information Supplementary Material. Acknowledgements We sincerely thank the reviewers for their insightful comments and constructive suggestions, which have significantly improved the quality and clarity of this manuscript. We also extend our gratitude to all the patients and their families for their participation and support, as well as to the medical and nursing teams at the Department of Hepatobiliary and Oncology Surgery, Wuhan Children’s Hospital, for their dedication to clinical care and data collection. Abbreviations Choledochal cysts Roux-en-Y hepaticojejunostomy Enhanced recovery after surgery Body mass index Hemoglobin Globulin Point-of-care ultrasound Total bilirubin Alanine aminotransferase Aspartate aminotransferase Albumin C-reactive protein Serum amylase Urine amylase Postoperative day Area under the receiver operating characteristic curve Concordance index Odds ratio Confidence interval Authors’ contributions Drs. Zhang and Yan had full access to all the data in the study and take responsibility for the integrity and accuracy of the data analysis. Qin and Liang contributed to the conception of the study. Zhu, Ji, and Liu contributed significantly to the analysis and manuscript preparation. Zhang and You performed the data analyses and wrote the manuscript. These authors contributed equally to this work and should be considered co-first authors.He and Duan helped perform the analysis through constructive discussions. All authors contributed to the article and approved the submitted version. Funding This work was supported by the Laboratory of Hepatobiliary and Pancreatic Diseases in Children (2025FEYJS005). Data availability The de-identified datasets generated and analysed during this study are provided in the supplementary file *Row Data.xlsx*. Declarations Ethics approval and consent to participate This study was approved by the Ethics Committee of Wuhan Children's Hospital of Huazhong University of Science and Technology (Approval No. 2024R030-E01). Owing to the retrospective design of the study, the need for informed consent was waived. Owing to the retrospective design of the study, the need for informed consent was waived by the ethics committee of Wuhan Children's Hospital of Huazhong University of Science and Technology. The study was conducted according to the principles of the Declaration of Helsinki. Consent for publication Not Applicable. This is a retrospective study. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material. Data Availability Statement The de-identified datasets generated and analysed during this study are provided in the supplementary file *Row Data.xlsx*.